临床上能否帮助病人克服对移植肾的排斥反应,是肾移植成败的关键问题之一,而对排斥反应的早期确诊又是处理排斥反应的前提。肾移植排斥反应的诊断指标已有很多报导,但目前仍在不断寻求新的指标。应用周围血液中淋巴细胞转化氚-胸腺嘧啶核苷掺入量测定(以下称掺入量测定)来判断肾移植的排斥反应或作为预示排斥反应的指标,国外有报导国内也有报导,并有的作了肯定的估价。由于以往对这一指标存在很大争论,而国内报导病例不多,为了累积资料,本文将我院在肾移植过程中使 Clinic can help patients to overcome the rejection of renal transplant rejection is one of the key issues in the success or failure of renal transplantation, and the early diagnosis of rejection is the premise to deal with rejection. There have been many reports on the diagnostic criteria for renal allograft rejection but new indicators are still being sought. Application of peripheral blood lymphocyte transformation tritiated - thymidine incorporation determination (hereinafter referred to as the amount of determination) to determine the rejection of renal transplantation or as an indicator of rejection prediction, foreign reports have also been reported in the country, and some Made a positive valuation. In the past, there was a lot of controversy about this indicator, but there were not many reported cases in China. In order to accumulate data, this article put our hospital in the process of kidney transplantation